Louis J. Ignarro

Louis J. Ignarro. An American pharmacologist whose groundbreaking research elucidated the role of nitric oxide as a crucial signaling molecule in the cardiovascular system. His work, which demonstrated how this gas dilates blood vessels and improves blood flow, earned him a share of the 1998 Nobel Prize in Physiology or Medicine. Ignarro's discoveries have had profound implications for understanding cardiovascular health and led to the development of important therapies like sildenafil (Viagra).

Early life and education

Born in Brooklyn, Ignarro developed an early interest in science. He pursued his undergraduate studies in pharmacy at the University of Minnesota, earning a Bachelor of Science degree. He then continued his academic journey at Columbia University, where he completed his Ph.D. in pharmacology. His doctoral research focused on the mechanisms of drug action, laying a foundational knowledge base for his future investigations into vascular physiology and cellular signaling pathways.

Research and career

Following his Ph.D., Ignarro held a research position at the pharmaceutical company Geigy before transitioning to academia. He served on the faculty of the Tulane University School of Medicine, where he began his seminal investigations into vascular smooth muscle relaxation. His key breakthrough came after moving to the University of California, Los Angeles (UCLA), where he definitively identified nitric oxide as the elusive endothelium-derived relaxing factor (EDRF). This discovery, made concurrently with the work of Robert F. Furchgott, revolutionized the understanding of blood pressure regulation, platelet function, and neurotransmission.

Nobel Prize in Physiology or Medicine

In 1998, Ignarro was awarded the Nobel Prize in Physiology or Medicine jointly with Robert F. Furchgott and Ferid Murad. The Nobel Assembly at the Karolinska Institute recognized their independent discoveries concerning "nitric oxide as a signalling molecule in the cardiovascular system." Ignarro's specific contribution was proving that nitric oxide was chemically identical to EDRF, a finding he presented at a pivotal conference at the Mayo Clinic. This work unveiled a fundamental biological principle where a simple gas acts as a critical regulator in organisms.

Later work and advocacy

After winning the Nobel Prize, Ignarro continued his research at UCLA, exploring the therapeutic applications of nitric oxide in conditions like atherosclerosis, hypertension, and heart failure. He became a prominent advocate for cardiovascular health, authoring the book *NO More Heart Disease*. He has also been a vocal proponent of the potential health benefits of specific nutritional supplements, particularly those containing the amino acid L-arginine and antioxidants like vitamin C, which he suggests can support the body's natural nitric oxide production.

Awards and honors

Beyond the Nobel Prize, Ignarro has received numerous prestigious accolades. These include the Basic Research Prize of the American Heart Association, the Roussel Uclaf Prize, and the Ciba Award from the American Society for Pharmacology and Experimental Therapeutics. He is an elected member of the United States National Academy of Sciences and the American Academy of Arts and Sciences. His work has been further honored by institutions like the University of Bologna and the Accademia dei Lincei.

Category:American pharmacologists Category:Nobel laureates in Physiology or Medicine Category:Columbia University alumni Category:University of California, Los Angeles faculty